Au revoir, arthritis.

In 2024, Bullfrog worked in partnership with Interpath to launch a new joint pain relief supplement, Epijoint®. But in talking to osteoarthritis sufferers, it became immediately clear that Epijoint® faced a significant market challenge.  Following years of untreatable pain and false hopes raised and swiftly dashed by inferior products, our audience frankly didn’t believe that anything was capable of easing what ailed them.

As a result, our first step was simple: if this new supplement could truly ease arthritic joint pain, we needed to prove it.

We did this by instigating  product research, the results of which highlighted  a  common theme; Epijoint® didn’t just help people feel less pain, in doing so it helped them feel more like themselves. 

This key learnings provided the framework for our strategy and go-to-market plan.

We began by driving a distinctive brand identity designed to signal a credible solution. Colours that cued genuine, and packaging that didn’t shout false claims – but rather exuded a quiet, confident and honest solution. We designed the visual identity from the bottle out, spanning logo development to website creation.

What we did

Product development

Partnership facilitation

Creative strategy

Marketing and channel strategy

Campaign development

Content production

Ambassador strategy

Social and experience activation

Engagement programs

Momentum generated

33%
INCREASE IN BRAND AWARENESS
62%
Increase in brand consideration
2.6M
WORKOUTS COMPLETE aT PARTNER GYMS
1.1M
HEALTH ASSESSMENTS COMPLETE

Direction - Move how you feel

Lorem ipsum

Solution 1 - Brand identity

Lorem ipsum

Solution 2 - Website

Lorem ipsum

Solution 3 - Campaign

Lorem ipsum

Solution 4 - Performance

Lorem ipsum

In their words

“Client quote or testimonial - Lorem ipsum dolor sit amet consectetur. Lectus auctor commodo cras ac id vulputate orci in. Sollicitudin convallis diam maecenas nibh odio. Mattis sagittis adipiscing nunc diam vivamus nulla sociis molestie neque. Nulla integer pharetra nisi tortor adipiscing sagittis aliquam tristique.”

Name name

Title here